Esthesioneuroblastoma, Olfactory
Esthesioneuroblastoma, Olfactory
Explore linked clinical trials. Standard reference: MESH:M002753811 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors | Carcinoma, Medullary, DNA Virus Infections, Esthesioneuroblastoma, Olfactory, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Tumor Virus Infections, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, adenocarcinoma, astrocytoma (excluding glioblastoma), benign urinary system neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, cervix disorder, cranial nerve neuropathy, cutaneous neuroendocrine carcinoma, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, glioblastoma, glioma, gonadal disorder, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, medullary thyroid gland carcinoma, melanocytic neoplasm, melanoma, neoplasm, nervous system disorder, neuroblastoma, neuroendocrine carcinoma, neuroendocrine neoplasm, neuroepithelial neoplasm, non-small cell lung carcinoma, olfactory nerve disorder, polyomavirus infectious disease, primitive neuroectodermal tumor, pulmonary large cell neuroendocrine carcinoma, respiratory system disorder, respiratory tract neoplasm, sinonasal undifferentiated carcinoma, skin disorder, skin neoplasm, testicular cancer, testicular disorder, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, uterine disorder, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2026-10-06 | NCT06814496 | |
| [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers | Esthesioneuroblastoma, Olfactory, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, cranial nerve neuropathy, epithelial neoplasm, kidney cancer, kidney disorder, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, nervous system disorder, neuroblastoma, neuroendocrine neoplasm, neuroepithelial neoplasm, olfactory nerve disorder, otorhinolaryngologic disease, paraganglioma, pheochromocytoma, primitive neuroectodermal tumor, urinary system disorder | Recruiting | Phase 1 | 2026-10-06 | NCT06479811 | |
| A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma | Esthesioneuroblastoma, Olfactory, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, cranial nerve neuropathy, epithelial neoplasm, neoplasm, nervous system disorder, neuroblastoma, neuroepithelial neoplasm, olfactory nerve disorder, primitive neuroectodermal tumor | Not yet recruiting | Phase 2 | 2026-10-05 | NCT07527169 | |
| Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors | Esthesioneuroblastoma, Olfactory, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, chondrosarcoma, connective tissue neoplasm, cranial nerve neuropathy, epithelial neoplasm, neoplasm, nervous system disorder, neuroblastoma, neuroepithelial neoplasm, olfactory nerve disorder, primitive neuroectodermal tumor, sarcoma, sinonasal undifferentiated carcinoma | Recruiting | Phase 2 | 2026-09-21 | NCT06176989 | |
| A Natural History Study of Children and Adults With Olfactory Neuroblastoma | Esthesioneuroblastoma, Olfactory, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, cranial nerve neuropathy, epithelial neoplasm, neoplasm, nervous system disorder, neuroblastoma, neuroepithelial neoplasm, olfactory nerve disorder, primitive neuroectodermal tumor | Recruiting | Not stated | 2026-08-17 | NCT04755205 | |
| Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). | Disease Attributes, Esthesioneuroblastoma, Olfactory, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, astrocytoma (excluding glioblastoma), central nervous system cancer, connective tissue neoplasm, cranial nerve neuropathy, diffuse intrinsic pontine glioma, endocrine system disorder, ependymoma, epithelial neoplasm, glioblastoma, glioma, malignant endocrine neoplasm, medulloblastoma, meningioma, neoplasm, nervous system disorder, neuroblastoma, neuroendocrine neoplasm, neuroepithelial neoplasm, olfactory nerve disorder, osteosarcoma, paraganglioma, pheochromocytoma, primitive neuroectodermal tumor, sarcoma, synovial sarcoma, tumor of meninges, vascular cancer | Recruiting | Phase 1 / Phase 2 | 2026-06-04 | NCT06607692 | |
| Long-Term Longitudinal QoL in Patients Undergoing EEA | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Esthesioneuroblastoma, Olfactory, Hernia, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Pituitary Neoplasms, Rathke Cleft Cysts, brain disorder, central nervous system cancer, central nervous system cyst, central nervous system disorder, central nervous system malformation, cephalocele, chondrosarcoma, chordoma, connective tissue neoplasm, cranial nerve neuropathy, craniopharyngioma, endocrine system disorder, epithelial neoplasm, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, meningioma, neoplasm, nervous system disorder, neuroblastoma, neuroepithelial neoplasm, olfactory nerve disorder, pituitary gland disorder, primitive neuroectodermal tumor, sarcoma, supratentorial cancer, tumor of meninges, vascular cancer | Active, not recruiting | Not stated | 2026-05-20 | NCT04087902 | |
| 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. | Esthesioneuroblastoma, Olfactory, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Pituitary Neoplasms, brain disorder, capillary hemangioma, central nervous system cancer, central nervous system disorder, cranial nerve neuropathy, endocrine system disorder, epithelial neoplasm, glioma, hemangioblastoma, hemangioma, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, medulloblastoma, meningioma, neoplasm, nervous system disorder, neuroblastoma, neuroendocrine neoplasm, neuroepithelial neoplasm, olfactory nerve disorder, paraganglioma, pituitary gland adenoma, pituitary gland disorder, primitive neuroectodermal tumor, supratentorial cancer, tumor of meninges, vascular cancer | Recruiting | Phase 4 | 2025-11-21 | NCT04081701 | |
| Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants | Esthesioneuroblastoma, Olfactory, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Stomatognathic Diseases, carcinoma, cranial nerve neuropathy, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, mouth disorder, neoplasm, nervous system disorder, neuroblastoma, neuroepithelial neoplasm, olfactory nerve disorder, primitive neuroectodermal tumor, salivary gland cancer, salivary gland disorder, squamous cell carcinoma | Recruiting | Not stated | 2025-10-28 | NCT00898638 | |
| An International Study on Pediatric Patients With Rare Tumors. | Digestive System Diseases, Digestive System Neoplasms, Esthesioneuroblastoma, Olfactory, Head and Neck Neoplasms, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Thoracic Neoplasms, Thymus Neoplasms, adenoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, carcinoma, connective tissue neoplasm, cranial nerve neuropathy, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, gastrointestinal stromal tumor, lymphatic system disorder, malignant endocrine neoplasm, melanocytic neoplasm, melanoma, mesothelial neoplasm, mesothelioma, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, nervous system disorder, neuroblastoma, neuroendocrine neoplasm, neuroepithelial neoplasm, nut midline carcinoma, olfactory nerve disorder, otorhinolaryngologic disease, pancreas disorder, pancreatic neoplasm, pleuropulmonary blastoma, primitive neuroectodermal tumor, skin disorder, skin neoplasm, thyroid gland carcinoma, thyroid gland disorder, thyroid tumor | Recruiting | Not stated | 2025-07-18 | NCT07072143 | |
| Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON) | Esthesioneuroblastoma, Olfactory, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, cranial nerve neuropathy, epithelial neoplasm, neoplasm, nervous system disorder, neuroblastoma, neuroepithelial neoplasm, olfactory nerve disorder, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2024-02-13 | NCT06255210 |